Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation

• Egile Nagusiak: Li-ying Jia (Egilea), Gui-yun Cao (Egilea), Jia Li (Egilea), Lu Gan (Egilea), Jin-xin Li (Egilea), Xin-yi Lan (Egilea), Zhao-qing Meng (Egilea), Xin He (Egilea), Chun-feng Zhang (Egilea), Chong-Zhi Wang (Egilea), Chun-Su Yuan (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

SheXiang XinTongNing (XTN), which is composed of six traditional Chinese herbs, is a commercially available Chinese patent medicine that has been widely used as the treatment of coronary heart disease (CHD). Its mechanisms against coronary heart disease, however, remain largely unknown. This study a...